Timasheva, Y,
Badykov, M,
Akhmadishina, L,
Nasibullin, T,
Badykova, E,
Pushkareva, A,
Plechev, V,
Sagitov, I,
Zagidullin, N (2021) by the inability of sinoatrial node to perform its pacemaker
function. Our aim was to identify genetic predictors
Pokhrel, P.,
Bennett, B.L.,
Regmi, S.,
Idrisov, B.,
Galimov, A.,
Akhmadeeva, L.,
Sussman, S. (2018) the mechanisms of how cultural orientation impacts health risk behaviors has been limited. This study
tested a
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to
test the therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) . The
tested compound is comparable, in terms of its activity to the hepatoprotective drug SAM according
of equimolar concentrations of the
test substances. Thromboelastography (TEG) was carried out with apparatus
Bogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) , with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We
tested the three